CANF insider transaction filings
Can-Fite BioPharma Ltd. — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-08. Screen CANF transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Farbstein Motti — CEO, CFO and COO | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Fishman Pnina — Chief Scientific Officer, Director | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CANF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →